A Protein’s Journey
Presentations | 2020 | Agilent TechnologiesInstrumentation
High-performance liquid chromatography (HPLC) is a cornerstone technique for characterization of proteins and other biomolecules, supporting drug discovery, bioprocess monitoring, and quality control in biopharmaceutical development. Precise separation of intact proteins, aggregates, charge variants, post-translational modifications, and small polar metabolites ensures product safety, efficacy, and regulatory compliance.
This application note presents a comprehensive survey of liquid chromatography modes for protein analysis. It compares reversed-phase (RP), size-exclusion (SEC), ion-exchange (IEX), hydrophobic interaction (HIC), hydrophilic interaction (HILIC), and affinity chromatography approaches. The goal is to guide selection of columns, mobile phases, and operating parameters to optimize resolution, throughput, and sample integrity.
Multiple chromatographic modes were evaluated using Agilent HPLC systems equipped with UV detectors at 220 nm, 254 nm, and 280 nm, as well as time-of-flight mass spectrometry for LC/MS workflows. Key column chemistries included:
These LC methods provide robust workflows for:
Emerging advances will further enhance protein analysis workflows:
A tailored combination of LC modes—reversed-phase, size-exclusion, ion-exchange, hydrophobic interaction, hydrophilic interaction, and affinity chromatography—enables comprehensive analysis of proteins and related biomolecules. By selecting appropriate columns, mobile phases, and operating conditions, researchers can achieve high sensitivity, resolution, and throughput to support drug discovery, bioprocess optimization, and quality control in modern biopharmaceutical laboratories.
HPLC, LC/MS
IndustriesProteomics
ManufacturerAgilent Technologies
Summary
Importance of the Topic
High-performance liquid chromatography (HPLC) is a cornerstone technique for characterization of proteins and other biomolecules, supporting drug discovery, bioprocess monitoring, and quality control in biopharmaceutical development. Precise separation of intact proteins, aggregates, charge variants, post-translational modifications, and small polar metabolites ensures product safety, efficacy, and regulatory compliance.
Goals and Study Overview
This application note presents a comprehensive survey of liquid chromatography modes for protein analysis. It compares reversed-phase (RP), size-exclusion (SEC), ion-exchange (IEX), hydrophobic interaction (HIC), hydrophilic interaction (HILIC), and affinity chromatography approaches. The goal is to guide selection of columns, mobile phases, and operating parameters to optimize resolution, throughput, and sample integrity.
Methodology and Instrumentation
Multiple chromatographic modes were evaluated using Agilent HPLC systems equipped with UV detectors at 220 nm, 254 nm, and 280 nm, as well as time-of-flight mass spectrometry for LC/MS workflows. Key column chemistries included:
- Reversed-phase: PLRP-S, AdvanceBio RP-mAb C18/C4/diphenyl (300 Å and larger pore sizes, 1.8 µm particles)
- Size-exclusion: Bio SEC columns (130 Å–300 Å pore sizes, 7.8 × 300 mm format)
- Ion-exchange: Bio IEX phases (SCX, SAX, WAX, WCX)
- Hydrophobic interaction: AdvanceBio HIC (Ammonium sulfate gradients 1–2 M)
- Hydrophilic interaction: AdvanceBio MS Spent Media and ZORBAX AAA HILIC columns (ACN/H2O, volatile buffers)
- Affinity: Protein A monoliths for 2D-LC capture and titer determination
Main Results and Discussion
- Reversed-phase chromatography resolves intact monoclonal antibodies and smaller peptides under denaturing conditions; larger pore sizes and elevated temperatures improve peak sharpness and recovery.
- Size-exclusion chromatography separates aggregates and monomers by hydrodynamic size; proper pore selection minimizes nonspecific interactions and run times.
- Ion-exchange chromatography distinguishes charge variants according to isoelectric point; buffer pH and ionic strength control binding and elution order of acidic versus basic proteins.
- Hydrophobic interaction chromatography retains native proteins via salt-promoted adsorption, enabling separation of oxidation and deamidation variants without unfolding.
- Hydrophilic interaction chromatography offers rapid LC/MS profiling of underivatized amino acids and metabolites in cell culture media using volatile ammonium salts and high organic content.
- Affinity capture using Protein A columns combined with SEC demonstrates effective purification and aggregate analysis in a two-dimensional workflow.
Benefits and Practical Applications
These LC methods provide robust workflows for:
- Biopharmaceutical development: structural integrity, purity, and potency assessment of therapeutic proteins.
- Quality control: routine monitoring of aggregates, charge variants, and glycan profiles.
- Process analytics: real-time tracking of nutrient utilization and metabolite production in bioreactors.
- High-throughput screening: LC/MS platforms for rapid identification of amino acids, small polar compounds, and biopharmaceutical impurities.
Future Trends and Opportunities
Emerging advances will further enhance protein analysis workflows:
- Ultra-high-pressure LC and superficially porous particles for sub-minute separations with high resolution.
- Integration of two-dimensional LC (e.g., IEX–RP, SEC–MS) for deeper characterization of complex mixtures.
- Bioinert system components to minimize sample loss of “sticky” proteins and glycoproteins.
- Expanded use of high-resolution MS detectors for comprehensive profiling of post-translational modifications and low-abundance variants.
Conclusion
A tailored combination of LC modes—reversed-phase, size-exclusion, ion-exchange, hydrophobic interaction, hydrophilic interaction, and affinity chromatography—enables comprehensive analysis of proteins and related biomolecules. By selecting appropriate columns, mobile phases, and operating conditions, researchers can achieve high sensitivity, resolution, and throughput to support drug discovery, bioprocess optimization, and quality control in modern biopharmaceutical laboratories.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
A Chromatographic Separation of Biological Macromolecules
2022|Agilent Technologies|Presentations
A Chromatographic Separation of Biological Macromolecules Mohit P. Patel Applications Engineer LC Columns and Consumables Technical Support September 15, 2022 DE95811172 Agilent Restricted Outline LC techniques for biomolecule analysis Reversed phase • Commonly used, wide column choice and denaturing conditions.…
Key words
advancebio, advancebiobio, biorestricted, restrictedzorbax, zorbaxsax, saxmonolith, monolithagilent, agilentplrp, plrpreversed, reversedrrhd, rrhdphase, phasemab, mabmapping, mappingsec, secglycan
SEC and IEX for BioMolecules - Column Selection and Troubleshooting
2022|Agilent Technologies|Presentations
SEC and IEX for Biomolecules Column selection and troubleshooting Jean Lane Application Engineer LC Columns and Consumables Technical Support April 28, 2022 1 April 28, 2022 SEC and IEX for BioMolecules: Column Selection and Troubleshooting Outline SEC and its mechanism…
Key words
iex, iexbio, biosec, secbuffer, bufferexchange, exchangecolumn, columnadvancebio, advancebiosax, saxmobile, mobilephase, phasepore, poremonolith, monolithconsiderations, considerationsvolume, volumesalt
Agilent BioHPLC Columns - Your essential resource for biomolecule analysis
2019|Agilent Technologies|Brochures and specifications
Agilent BioHPLC Columns Your essential resource for biomolecule analysis Who We Are. What We Do. Across the lab, around the world, with you every step of the way. CrossLab is an Agilent capability that integrates services, consumables and lab-wide resource…
Key words
biohplc, biohplccolumns, columnsadvancebio, advancebioagilent, agilentsize, sizebio, bioanalysis, analysisparticle, particlespecialty, specialtymin, minprotein, proteinmau, mauvariant, varianttips, tipsamino
Making the Leap - Small Molecule – Biologics
2020|Agilent Technologies|Presentations
Making the Leap Small Molecule – Biologics Rita Steed LC Columns Application Engineer May 8, 2019 1 May 8, 2019 Small molecule – Biologics Agilent Restricted Outline • Small and/or biomolecules; similarities/differences • Column choice • Things to consider •…
Key words
biologics, biologicsrestricted, restrictedmolecule, moleculesmall, smallagilent, agilentporoshell, poroshellinfinitylab, infinitylabadvancebio, advancebiodiffusion, diffusionsize, sizemab, mabphase, phasedeemter, deemtermau, mauvan